background preloader

Veille sanitaire en Europe

Facebook Twitter

PARLEMENT EUROPEEN - Réponse à question E-002227-17 Increased incidence of colon cancer. Colon cancers are ranked second in frequency among the most aggressive cancers in Romania.

PARLEMENT EUROPEEN - Réponse à question E-002227-17 Increased incidence of colon cancer

The number of these cancers has tripled in the last 27 years. In spite of the fact that 10 years ago a national programme for colon cancer screening was approved, the programme does not receive the necessary funding. Consequently, the number of those cancers has multiplied in the past decade. Detecting the disease before clinical symptoms appear is essential because when cancer is detected at an early stage, subsequent treatment is less invasive and has a higher success rate. Across Europe, these screening programmes have been in place for the past few years, and colon cancers have been reduced by 20%. JOUE 04/06/14 Décision 2014/C 167/05 de la commission du 3 juin 2014 instituant un groupe d’experts de la Commission sur la lutte contre le cancer et abrogeant la décision 96/469/CE. PARLEMENT EUROPEEN - Réponse à question E-003117-15 Augmentation alarmante des décès dus au cancer dans les pays en développement.

L'Organisation mondiale de la Santé alerte la communauté internationale sur le fait qu'une majorité de décès dus au cancer surviennent dans les pays en développement.

PARLEMENT EUROPEEN - Réponse à question E-003117-15 Augmentation alarmante des décès dus au cancer dans les pays en développement

Ainsi en 2012, huit des 14,1 millions de nouveaux cas de cancer ont été enregistrés dans les régions en développement et ces proportions ne cesseront d'augmenter dans les années à venir. Ann. Ist. Super. Sanità vol.50 n.2 Roma Apr./Jun. 2014 Cancer incidence in Italian contaminated sites. Cancer incidence in Italian contaminated sites Pietro CombaI; Paolo RicciII,III; Ivano IavaroneI; Roberta PirastuIV; Carlotta BuzzoniIII,VI; Mario FuscoIII,VII; Stefano FerrettiIII,VIII; Lucia FazzoI; Roberto PasettoI; Amerigo ZonaI; Emanuele CrocettiIII, V; for ISS-AIRTUM Working Group for the study of cancer incidence in contaminated sites* IDipartimento di Ambiente e Connessa Prevenzione Primaria, Istituto Superiore di Sanità, Rome, Italy IIRegistro Tumori di Mantova, Mantua, Italy IIIAIRTUM, Associazione Italiana dei Registri Tumori, Italy IVDipartimento di Biologia e Biotecnologie "Charles Darwin", Sapienza Università di Roma, Rome, Italy VUnità di Epidemiologia Clinica e Descrittiva, Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy VIRegistro Tumori di Napoli (ASL Napoli 4), Naples, Italy VIIRegistro Tumori di Ferrara, Dipartimento di Chirurgia e Medicina Sperimentale, Università degli Studi di Ferrara, Ferrara, Italy Address for correspondence INTRODUCTION.

Ann. Ist. Super. Sanità vol.50 n.2 Roma Apr./Jun. 2014 Cancer incidence in Italian contaminated sites

M. LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE 06/12/13 Large differences in cancer survival between European countries still rema. Cancer survival still varies widely between European countries despite major improvements in cancer diagnosis and treatment during the first decade of the 21st century, according to the latest EUROCARE-5 reports covering over 50% of the adult and 77% of the childhood population of Europe.

LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE 06/12/13 Large differences in cancer survival between European countries still rema

The number of adults surviving for at least five years after diagnosis has risen steadily over time in all European regions, reflecting major advances in cancer management such as organised cancer screening programmes and improved treatments. However, there continues to be big disparities between countries. Michel Coleman, Professor of Epidemiology and Vital Statistics at the London School of Hygiene & Tropical Medicine and co-author on the adult study said: “EUROCARE-5 updates what we know about survival for cancer patients in Europe. Cancer survival still varies widely across Europe, despite widespread improvements in the first decade of this century.

Veille sanitaire Cancer en France

EFSA 31/07/13 Chronic toxicity and carcinogenicity studies whole food/feed. EFSA Journal 2013;11(7):3347 [18 pp.]. doi:10.2903/j.efsa.2013.3347 Type: Scientific Report of EFSA On request from: European Commission Question number: EFSA-Q-2013-00316 Approved: 26 July 2013 Published: 31 July 2013 Affiliation: European Food Safety Authority (EFSA) Parma Italy Upon request from the European Commission, the European Food Safety Authority prepared a scientific report that would aid the future establishment of protocols for chronic toxicity and/or carcinogenicity studies in rodents with whole food/feed.

EFSA 31/07/13 Chronic toxicity and carcinogenicity studies whole food/feed.

This scientific report provides a commentary on OECD TG 453 with considerations on its applicability to support the safety assessment of long term consumption of a given food with respect to its chronic toxicity or carcinogenicity potential. EFSA 31/07/13 L’EFSA publie des principes directeurs pour des études sur deux ans portant sur des aliments entiers. Nouvelle 31 juillet 2013 L’EFSA a présenté des principes directeurs qui aideront les scientifiques à mener des études sur deux ans portant sur des aliments entiers visant à évaluer le risque de cancer et/ou de toxicité que présente la consommation de longue durée de tels aliments pour l’homme.

EFSA 31/07/13 L’EFSA publie des principes directeurs pour des études sur deux ans portant sur des aliments entiers

Le rapport contient des conseils concernant la conception et la conduite d’essais d’alimentation menés sur des aliments entiers chez des rongeurs, conformément aux normes internationalement reconnues, et identifie les limites de ces types d’études. En outre, l’Autorité souligne le fait qu’une décision relative à la nécessité de ces études doit être prise au cas par cas et seulement après que toutes les données toxicologiques, nutritionnelles et compositionnelles existantes auront été évaluées. EFSA Journal 2012;10(3):2578 [5 pp.]. Statement on the applicability of the Margin of Exposure approach for the safety assessmen.

EFSA Journal 2012;10(3):2578 [5 pp.]. doi:10.2903/j.efsa.2012.2578 Type: Statement of the Scientific Committee/Scientific Panel On request from: EFSA Question number: EFSA-Q-2012-00233 Adopted: 08 February 2012 Published: 30 March 2012 Affiliation: European Food Safety Authority (EFSA), Parma, Italy Following a request from EFSA, the Scientific Committee was asked to deliver a statement on the applicability of the margin of exposure approach for the safety assessment of impurities which are both genotoxic and carcinogenic in substances added to food or feed.

EFSA Journal 2012;10(3):2578 [5 pp.]. Statement on the applicability of the Margin of Exposure approach for the safety assessmen

The Scientific Committee acknowledges that analytical methodology is continually improving, and an increasing number of impurities, including some substances which are both genotoxic and carcinogenic, can be detected at low levels in, for example, food/feed additives or food contact materials. As a result it can be foreseen that these impurities may end up in food, including products from animal origin.